Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
357
Frequently Asked Questions
What is Market Cap of Vericel Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Vericel Corp market cap is $1.59B.
What is the 52-week high for Vericel Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vericel Corp 52 week high is $63.00 as of October 03, 2025.
What is the 52-week low for Vericel Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vericel Corp 52 week low is $29.24 as of October 03, 2025.
What is Vericel Corp stock price today?
Vericel Corp stock price today is $31.52.
What was Vericel Corp stock price yesterday?
Vericel Corp stock price yesterday was $30.91.
What is the PE ratio of Vericel Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Vericel Corp’s P/E ratio is 252.77.
What is the Price-to-Book ratio of Vericel Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Vericel Corp P/B ratio is 5.1821.
What is the 50-day moving average of Vericel Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Vericel Corp 50-day moving average is $34.68.
